Precision Optics Corporation, Inc. (POCI)
NASDAQ: POCI · Real-Time Price · USD
4.600
+0.290 (6.73%)
Nov 6, 2024, 4:00 PM EST - Market closed

Company Description

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.

The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.

It also provides components and assemblies for industrial and military use. It markets its products to medical device companies.

Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts.

Precision Optics Corporation, Inc.
Precision Optics Corporation logo
Country United States
Founded 1982
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 84
CEO Joseph Forkey

Contact Details

Address:
22 East Broadway
Gardner, Massachusetts 01440
United States
Phone 978 630 1800
Website poci.com

Stock Details

Ticker Symbol POCI
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency USD
CIK Code 0000867840
CUSIP Number 740294400
ISIN Number US7402944000
Employer ID 04-2795294
SIC Code 3845

Key Executives

Name Position
Richard E. Forkey Founder, Advisor to the Chief Executive Officer and Director Emeritus
Dr. Joseph N. Forkey Chief Executive Officer, President, Treasurer and Director
Wayne M. Coll Chief Financial Officer and Secretary
Mahesh Lawande Chief Operating Officer
Clay Schwabe Vice President of Sales and Marketing
Stephanie R. Hansen Director of Human Resources
Divaker Mangadu President of Ross Optical Division

Latest SEC Filings

Date Type Title
Oct 28, 2024 10-K/A [Amend] Annual report
Oct 1, 2024 8-K Current Report
Sep 30, 2024 10-K Annual Report
Aug 15, 2024 424B5 Filing
Aug 14, 2024 8-K Current Report
Jul 3, 2024 8-K Current Report
Jun 14, 2024 EFFECT Notice of Effectiveness
Jun 11, 2024 S-3/A [Amend] Registration statement under Securities Act of 1933
Jun 11, 2024 UPLOAD Filing
Jun 7, 2024 S-3 Registration statement under Securities Act of 1933